- Home
- Research
- Research & Economic Development
- Development Compliance
- Institutional Biosafety Committee
Research & Economic Development
Office of Vice PresidentDivision Units
Biomedical Research CenterComputational Research CtrGrants & Contracts- Contact
- Cost Accounting Standards
- Department Training Manual
- Federal Information
- Forms
- Grants Management
- Main Page
- Proposals
- Feedback- IRB Federal Regs Changes
- Policies and Procedures
- IRB Forms
- Human Subject Education
- Schedule of Meetings
- IRB Members
- Research Participants
- Fed. Reg. & Guidelines
- Frequently Asked Questions
- IRB Links
- Main Page
- Contact
- External Funding
- Internal Funding
- Forms
- Main Page
- Proposal Preparation
- Compliance Policies and Procedures
Division Information
Add'l Resources/InformationCommittees- Associate Deans for Research
- Conflict of Interest/Scientific Misconduct
- Institutional Animal Care and Use Committee (IACUC)
- Institutional Biosafety Committee
- Intellectual Property Committee
- Radiation Safety and Hazardous Materials Committee
- Senate of Scholarly Activities
Institutional Biosafety Committee
The University of North Dakota Institutional Biosafety Committee (IBC) requires that any biological research or teaching activities, particularly those utilizing DNA, recombinant DNA, transgenic organisms, or biohazardous research material, be subject to a University Review Process and that these activities must be approved by the IBC prior to their initiation. The IBC is the only authorized University committee that can give approval to projects and activities involving DNA, recombinant DNA and biohazardous research material. The IBC will follow UND laboratory biosafety guidelines and the NIH guidelines for DNA, recombinant DNA and biohazardous material research in determining the suitability of projects and activities. For any proposed activity not approved by the IBC, an explanation of that decision will be provided. Any project or activity not approved can be revised and resubmitted to the IBC for consideration.
All faculty or staff who plan on using recombinant DNA, biohazardous materials or conducting activities that involve the handling of biological materials in a research setting (live or dead animals, plant or animal pathogens, tissue, blood, bodily secretions, nucleic acids, toxins, etc.), teaching, or other activities must submit a completed, signed application form to the IBC Office, University of North Dakota, Twamley Hall Room 106, 264 Centennial Dr, Stop 7134, Grand Forks, ND 58202-7134. All approved projects must be reviewed on an annual basis and any significant protocol changes must be approved as well.
All principal investigators should be familiar with the laboratory biosafety ( http :// www . cdc .gov/od/ohs/ biosfty /bmbl5/bmbl5 toc . htm ) and the NIH guidelines for recombinant DNA research ( http ://www4.od. nih .gov/ oba / rac /guidelines/guidelines. html )
One copy of all funded grant applications utilizing recombinant DNA or biohazardous materials must be submitted to the IBC. The PI will not be able to access grant funds or begin the project until the IBC has reviewed and approved the project. Any changes to an approved project must receive IBC approval prior to their implementation.
Anyone having questions regarding the IBC application process should contact the Research Development and Compliance (RD&C) office at the address listed above or call the Administrative Secretary at (701)777-4279.
Forms
If you have questions or problems with the forms below, please contact rdc @mail. und . nodak . edu
IBC Application |
| Must be completed annually. |
IBC Protocol Change Form |
| Must be completed when major protocol changes have been instituted in the approved project. |
Institutional Biosafety Manual |
Bloodborne Pathogen Training |
Membership as of May 5, 2011
| Name | Address | Phone | Term | Highest Degree | Scientific Specialty |
| David Bradley | Microbiology, UND Stop 9037 |
777-2214 777-2786 |
5/5/08 | Ph.D. | Microbiology |
| Lucia Carvelli | Pharmacology, Physiology & Therapeutics, UND Stop 9037 |
777-4293 | 04/26/11 | Ph.D. | Biological Science/Pharmacology |
| Scott Garrett** | Pathology, UND Stop 9037 |
777-2657 777-2561 |
4/5/05 |
Ph.D. | Pathology |
| Tim M. Heinley | Student Health Services, UND Stop 9038 |
777-4836 777-3963 |
11/12/99 |
Ph.D. | Family Medicine |
| Kap J. Lee | Director, Center for Biomedical Research, UND Stop 9001 |
777-4493 777-3310 |
2/25/98 |
M.D. | Veterinary Medicine |
| Barry Milavetz**** | Associate Vice President for Research, UND Stop 7134 |
777-4280 777-2054 |
Ex Officio |
D.V.M. | Biochemistry |
| Matthew L. Nilles* | Biochemistry and Molecular Biology, UND Stop 9037 |
777-3341 | 11/15/01 | Ph.D. | Microbiology; Bacterial Pathogenesis |
| Eric Pearson | Environmental Health and Safety Manager, UND Stop 9031 |
777-3341 | 11/26/07 | B.S. | Environmental Health and Safety Manager |
| Garry A. Pearson*** | Christensen, Pearson & Fischer Law Offices 24 North 4th Grand Forks, ND |
775-0521 | 11/18/87 | J.D. | Attorney |
| James E. Porter | Pharmacology, Physiology & Therapeutics, UND Stop 9037 |
777-4293 | 4/22/03 | Ph.D | Pharmacology |
| Steven G. Ralph | Biology, UND Stop 9037 |
777-4673 777-2621 |
12/15/09 | Ph.D. | Assistant Professor |
| Linda M. Ray | Pathology, UND Stop 9037 |
777-3687 777-3937 |
8/25/97 | B.S. | Clinical Laboratory Scientist |
| James Schothorst*** | Environmental Health Specialist 151 S. 4th St. Ste. N -301, Grand Forks, ND 58201 |
787-8109 |
6/1/08 | ||
| Jefferson A. Vaughan | Biology, UND Stop 9019 |
777-2199 |
5/14/03 | Ph.D. | Medical Entomology and Vector-Borne Diseases |
| Min Wu | Biochemistry & Molecular Biology, UND Stop 9037 |
777-4875 | 05/02/11 | Ph.D. | Assistant Professor |
| *Chairman **Vice-Chairman ***Community Member ****Non-voting Member |
|||||
IRB Main Page